Stock EWL EDWARDS LIFESCIENCES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Edwards Lifesciences Corporation BOERSE MUENCHEN

Equities

EWL

US28176E1082

Real-time BOERSE MUENCHEN
Other stock markets
 20:43:21 27/05/2024 BST 		5-day change 1st Jan Change
81.55 EUR +0.48% Intraday chart for Edwards Lifesciences Corporation -0.92% +16.67%
05-23 Some of the biggest splits in Corporate America RE
05-22 Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT

Evolution of the average Target Price on Edwards Lifesciences Corporation

Price target over the last 5 years

History of analyst recommendation changes

b9a48b46a13802d.ThM221tDf-aK94OLSlKC_0AfAygmwXIlnI107SVV33Y.Jyp1kyMEKNPkksnRfzDLvjVRehwfrQFs-sEDnAgPnS8ca1qILTEQ1s_a5A~2b6d12e0e099f8fbf0a45b453a46350f

Analyst Recommendations on Edwards Lifesciences Corporation

Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98 MT
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86 MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing MT
Barclays Adjusts Edwards Lifesciences Price Target to $101 From $100 MT
Edwards Lifesciences Insider Sold Shares Worth $1,212,687, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $622,062, According to a Recent SEC Filing MT
Bernstein Adjusts Price Target on Edwards Lifesciences to $73 From $72 MT
Evercore ISI Adjusts Price Target on Edwards Lifesciences to $89 From $92 MT
Stifel Adjusts Price Target on Edwards Lifesciences to $85 From $83 MT
Wells Fargo Adjusts Price Target on Edwards Lifesciences to $99 From $94 MT
UBS Adjusts Edwards Lifesciences Price Target to $95 From $92, Maintains Neutral Rating MT
Piper Sandler Adjusts Price Target on Edwards Lifesciences to $88 From $85 MT
Canaccord Genuity Trims Price Target on Edwards Lifesciences to $85 From $86 MT
Baird Adjusts Edwards Lifesciences Price Target to $102 From $100 MT
Leerink Partners Adjusts Edwards Lifesciences' Price Target to $93 From $96, Keeps Market Perform Rating MT
ANALYST RECOMMENDATIONS : AMD, Colgate, Fair Isaac, Tyson Foods, AstraZeneca Our Logo
Zacks Investment Research Adjusts Price Target on Edwards Lifesciences to $95 From $97 MT
Truist Securities Adjusts Edwards Lifesciences Price Target to $105 From $97, Buy Rating Kept MT
RBC Raises Price Target on Edwards Lifesciences to $101 From $95, Keeps Outperform Rating MT
Mizuho Securities Adjusts Price Target on Edwards Lifesciences to $105 From $95, Maintains Buy Rating MT
Edwards Lifesciences Insider Sold Shares Worth $1,154,142, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $1,329,472, According to a Recent SEC Filing MT
Edwards Lifesciences Insider Sold Shares Worth $2,712,418, According to a Recent SEC Filing MT
Citigroup Raises Price Target on Edwards Lifesciences to $98 From $90, Maintains Neutral Rating MT
Edwards Lifesciences Insider Sold Shares Worth $688,423, According to a Recent SEC Filing MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.98 USD
Average target price
96.16 USD
Spread / Average Target
+9.30%
High Price Target
105 USD
Spread / Highest target
+19.35%
Low Price Target
73 USD
Spread / Lowest Target
-17.03%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Edwards Lifesciences Corporation

Citigroup
Deutsche Bank Securities
Barclays
Bernstein
Evercore ISI
Stifel Nicolaus
Wells Fargo Securities
UBS
Piper Sandler
Canaccord Genuity
Baird
Leerink Partners
Zacks Investment Research
Truist Securities
RBC Capital Markets
Mizuho Securities
Morgan Stanley
Oppenheimer
BofA Securities
Jefferies & Co.
JPMorgan Chase
Wolfe Research
TD Cowen
Raymond James
Goldman Sachs
Cowen
SVB Leerink
Credit Suisse
Atlantic Equities

Ratings for Edwards Lifesciences Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. EW Stock
  4. EWL Stock
  5. Consensus Edwards Lifesciences Corporation